Thiolated glycol chitosan bearing α-cyclodextrin for sustained delivery of pegylated human growth hormone

Journal of Biomaterials Science, Polymer Edition

Volumn 23, Issue 15, 2012, Pages 1995-2005

  Sivasubramanian, Maharajan ^a   Kim, Yu Jeong ^a   Chae, Su Young ^b   Son, Sohee ^b   Jo, Dong Gyu ^b   Lee, Kang Choon ^b   Yoo, Chang Kyoo ^a   Park, Jae Hyung ^a,b  

^a Kyung Hee University   (South Korea)

^b Sungkyunkwan University   (South Korea)

Author keywords

cyclodextrin; Glycol chitosan; In situ cross linking; PEG hGH; Protein delivery

Indexed keywords

BIOLOGICAL FLUIDS; CHEMICAL CROSS-LINKING; CROSS-LINKED COMPLEX; DIACRYLATES; GLYCOL CHITOSAN; HUMAN GROWTH HORMONE; IN-SITU; IN-VITRO; INCLUSION COMPLEX; INNER CAVITIES; PEG-HGH; PHYSICAL INTERACTIONS; PROTEIN DELIVERY; PROTEIN THERAPEUTICS; RELEASE RATE; SUSTAINED RELEASE;

ADDITION REACTIONS; CIRCULAR DICHROISM SPECTROSCOPY; CROSSLINKING; GLYCOLS; POLYETHYLENE GLYCOLS; PROTEINS;

CHITOSAN;

ACRYLIC ACID; ALPHA CYCLODEXTRIN; CHITOSAN DERIVATIVE; GROWTH HORMONE; POLY(ETHYLENE GLYCOL) DIACRYLATE; UNCLASSIFIED DRUG; ALPHA CYCLODEXTRIN DERIVATIVE; ALPHA-CYCLODEXTRIN; CHITOSAN; DELAYED RELEASE FORMULATION; GLYCOL-CHITOSAN; HORMONE; HUMAN GROWTH HORMONE; MACROGOL DERIVATIVE; POLY(ETHYLENE GLYCOL)DIACRYLATE;

ARTICLE; CIRCULAR DICHROISM; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG STRUCTURE; HUMAN; IN VITRO STUDY; MICHAEL ADDITION; PH; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG RELEASE; EVALUATION STUDY; PROTON NUCLEAR MAGNETIC RESONANCE; SYNTHESIS; X RAY DIFFRACTION;

ALPHA-CYCLODEXTRINS; CHITOSAN; CIRCULAR DICHROISM; DELAYED-ACTION PREPARATIONS; DRUG LIBERATION; HORMONES; HUMAN GROWTH HORMONE; HUMANS; POLYETHYLENE GLYCOLS; PROTON MAGNETIC RESONANCE SPECTROSCOPY; X-RAY DIFFRACTION;

EID: 84867203810     PISSN: 09205063     EISSN: 15685624     Source Type: Journal    
DOI: 10.1163/092050611X603700     Document Type: Article

References (31)

1. B. Leader, Q. J. Baca and D. E. Golan, Nature Rev. Drug Discov. 7, 21 (2008).
2. K. Fu, A. M. Klibanov and R. Langer, Nature Biotechnol. 18, 24 (2000).
3. K. Fu, D. W. Pack, A. M. Kilbanov and R. Langer, Pharm. Res. 17, 100 (2000).
4. O. L. Johnson, J. L. Cleland, H. J. Lee, M. Charnis, E. Duenas, W. Jaworowicz, D. Shepard, A. Shahzamani, A. J. Jones and S. D. Putney, Nature Med. 2, 795 (1996).
5. Y. Yeo, O. A. Basaran and K. Park, J. Control. Rel. 93, 161 (2003).
6. J. H. Park, M. Ye, Y. Yeo, W. K. Lee, C. Paul and K. Park, Mol. Pharmacol. 3, 135 (2005).
7. T. Higashi, F. Hirayama, S. Misumi, H. Arima and K. Uekama, Biomaterials 29, 3866 (2008).
8. J. M. Harris and R. B. Chess, Nature Rev. Drug Discov. 2, 214 (2003).
9. J. S. Kang, P. P. DeLuca and K. C. Lee, Exp. Opin. Emerg. Drugs 14, 363 (2009).
10. V. Wagner, A. Dullaart, A. K. Bock and A. Zweck, Nature Biotechnol. 24, 1211 (2006).
11. T. Higashi, F. Hirayama, H. Arima and K. Uekama, Bioorg. Med. Chem. Lett. 17, 1871 (2007).
12. Y. J. Kim, S. Y. Chae, C. H. Jin, M. Sivasubramanian, S. Son, K. Y. Choi, D. G. Jo, K. Kim, I. C. Kwon, K. C. Lee and J. H. Park, Biomaterials 31, 9057 (2010).
13. W. Bouquet, T. Boterberg, W. Ceelen, P. Pattyn, M. Peeters, M. Bracke, J. P. Remon and C. Ver-vaet, Int. J. Pharm. 367, 148 (2009).
14. F. Quaglia, L. Ostacolo, A. Mazzaglia, V. Villari, D. Zaccaria and M. T. Sciortino, Biomaterials 30, 374 (2009).
15. S. Swaminathan, L. Pastero, L. Serpe, F. Trotta, P. Vavia, D. Aquilano, M. Trotta, G. Zara and R. Cavalli, Eur. J. Pharm. Biopharm. 74, 193 (2010).
16. A. Harada, Coord. Chem. Rev. 148, 115 (1996).
17. A. Harada and M. Kamachi, Macromolecules 23, 2821 (1990).
18. M. S. Huh, S. Y. Lee, S. Park, S. Lee, H. Chung, S. Lee, Y. Choi, Y. K. Oh, J. H. Park, S. Y. Jeong, K. Choi, K. Kim and I. C. Kwon, J. Control. Rel. 144, 134 (2010).
19. S. J. Lee, K. Park, Y. K. Oh, S. H. Kwon, S. Her, I. S. Kim, K. Choi, S. J. Lee, H. Kim, S. G. Lee, K. Kim and I. C. Kwon, Biomaterials 30, 2929 (2009).
20. K. H. Min, K. Park, Y. S. Kim, S. M. Bae, S. Lee, H. G. Jo, R. W. Park, I. S. Kim, S. Y. Jeong, K. Kim and I. C. Kwon, J. Control. Rel. 127, 208 (2008).
21. H. Y. Nam, S. M. Kwon, H. Chung, S. Y. Lee, S. H. Kwon, H. Jeon, Y. Kim, J. H. Park, J. Kim, S. Her, Y. K. Oh, I. C. Kwon, K. Kim and S. Y. Jeong, J. Control. Rel. 135, 259 (2009).
22. G. Saravanakumar, K. H. Min, D. S. Min, A. Y. Kim, C. M. Lee, Y. W. Cho, S. C. Lee, K. Kim, S. Y. Jeong, K. Park, J. H. Park and I. C. Kwon, J. Control. Rel. 140, 210 (2009).
23. S. Y. Chae, T. H. Kim, K. Park, C. H. Jin, S. Son, S. Lee, Y. S. Youn, K. Kim, D. G. Jo, I. C. Kwon, X. Chen and K. C. Lee, Mol. Cancer Ther. 9, 1719 (2010).
24. Y. Youn, M. Shin, S. Chae, C. H. Jin, T. Kim and K. Lee, Biotechnol. Lett. 29, 713 (2007).
25. M. Prabaharan and S. Gong, Carbohydr. Polym. 73, 117 (2008).
26. K. Kafedjiiski, R. K. R. Jetti, F. Föger, H. Hoyer, M. Werle, M. Hoffer and A. Bernkop-Schnürch, Int. J. Pharm. 343, 48 (2007).
27. S. D. Putney and P. A. Burke, Nature Biotechnol. 16, 153 (1998).
28. H. Gao, Y. N. Wang, Y. G. Fan and J. B. Ma, J. Biomed. Mater. Res. A 80, 111 (2007).
29. F. van de Manakker, K. Braeckmans, N. E. Morabit, S. C. De Smedt, C. F. van Nostrum and W. E. Hennink, Adv. Funct. Mater. 19, 2992 (2009).
30. M. Sukumar, S. M. Storms and M. R. De Felippis, Pharm. Res. 22, 789 (2005).
31. T. Higashi, F. Hirayama, S. Yamashita, S. Misumi, H. Arima and K. Uekama, Int. J. Pharm. 374, 26 (2009).